Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE9.5700
- TODAY'S CHANGE (%)0.2000 (2.1345%)
- Bid / Lots9.0000/ 10
- Ask / Lots9.7500/ 26
- Open / Previous Close9.4000 / 9.3700
- Day Range
- 52 Week Range
- Volume737,185
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 14508 | 9.4 |
| 09:34 ET | 4725 | 9.32 |
| 09:36 ET | 3021 | 9.4 |
| 09:38 ET | 2800 | 9.48 |
| 09:39 ET | 2400 | 9.55 |
| 09:41 ET | 5124 | 9.485 |
| 09:43 ET | 1100 | 9.5099 |
| 09:45 ET | 450 | 9.53 |
| 09:48 ET | 3700 | 9.51 |
| 09:50 ET | 2249 | 9.49 |
| 09:52 ET | 1340 | 9.46 |
| 09:54 ET | 869 | 9.54 |
| 09:56 ET | 40900 | 9.5 |
| 09:57 ET | 1824 | 9.58 |
| 09:59 ET | 1290 | 9.62 |
| 10:01 ET | 4500 | 9.63 |
| 10:03 ET | 1000 | 9.5962 |
| 10:06 ET | 3340 | 9.56 |
| 10:08 ET | 400 | 9.53 |
| 10:10 ET | 4778 | 9.484 |
| 10:12 ET | 53100 | 9.55 |
| 10:14 ET | 2136 | 9.53 |
| 10:15 ET | 884 | 9.565 |
| 10:17 ET | 600 | 9.55 |
| 10:21 ET | 1000 | 9.5664 |
| 10:24 ET | 1800 | 9.52 |
| 10:28 ET | 300 | 9.52 |
| 10:30 ET | 1200 | 9.51 |
| 10:32 ET | 1493 | 9.51 |
| 10:33 ET | 1384 | 9.54 |
| 10:35 ET | 600 | 9.52 |
| 10:39 ET | 2034 | 9.51 |
| 10:42 ET | 1364 | 9.5 |
| 10:44 ET | 6263 | 9.43 |
| 10:46 ET | 408 | 9.42 |
| 10:48 ET | 1400 | 9.46 |
| 10:51 ET | 1162 | 9.46 |
| 10:53 ET | 127 | 9.47 |
| 10:55 ET | 100 | 9.45 |
| 10:57 ET | 1447 | 9.47 |
| 11:00 ET | 806 | 9.46 |
| 11:02 ET | 557 | 9.48 |
| 11:04 ET | 200 | 9.48 |
| 11:06 ET | 350 | 9.48 |
| 11:08 ET | 2000 | 9.47 |
| 11:09 ET | 2214 | 9.5 |
| 11:11 ET | 1013 | 9.48 |
| 11:13 ET | 200 | 9.46 |
| 11:15 ET | 1068 | 9.48 |
| 11:18 ET | 700 | 9.48 |
| 11:20 ET | 500 | 9.49 |
| 11:22 ET | 955 | 9.52 |
| 11:26 ET | 486 | 9.53 |
| 11:27 ET | 3505 | 9.52 |
| 11:29 ET | 3932 | 9.54 |
| 11:31 ET | 1295 | 9.53 |
| 11:36 ET | 225 | 9.52 |
| 11:38 ET | 733 | 9.51 |
| 11:40 ET | 1628 | 9.51 |
| 11:42 ET | 2500 | 9.5 |
| 11:44 ET | 815 | 9.51 |
| 11:45 ET | 700 | 9.505 |
| 11:47 ET | 534 | 9.5 |
| 11:49 ET | 1835 | 9.54 |
| 11:51 ET | 200 | 9.5398 |
| 11:56 ET | 1254 | 9.54 |
| 11:58 ET | 205 | 9.53 |
| 12:00 ET | 2073 | 9.51 |
| 12:02 ET | 826 | 9.505 |
| 12:03 ET | 200 | 9.5 |
| 12:05 ET | 500 | 9.48 |
| 12:07 ET | 5233 | 9.5 |
| 12:12 ET | 927 | 9.4734 |
| 12:14 ET | 559 | 9.44 |
| 12:16 ET | 300 | 9.42 |
| 12:18 ET | 1338 | 9.4201 |
| 12:20 ET | 400 | 9.41 |
| 12:21 ET | 500 | 9.41 |
| 12:23 ET | 300 | 9.41 |
| 12:25 ET | 1250 | 9.4405 |
| 12:27 ET | 1100 | 9.435 |
| 12:30 ET | 3100 | 9.43 |
| 12:32 ET | 2700 | 9.43 |
| 12:34 ET | 200 | 9.42 |
| 12:36 ET | 900 | 9.43 |
| 12:38 ET | 300 | 9.42 |
| 12:39 ET | 500 | 9.43 |
| 12:41 ET | 1800 | 9.46 |
| 12:43 ET | 701 | 9.43 |
| 12:45 ET | 13707 | 9.51 |
| 12:50 ET | 1250 | 9.51 |
| 12:52 ET | 100 | 9.48 |
| 12:54 ET | 336 | 9.465 |
| 12:56 ET | 1700 | 9.48 |
| 12:59 ET | 250 | 9.485 |
| 01:01 ET | 350 | 9.48 |
| 01:03 ET | 3994 | 9.5 |
| 01:06 ET | 200 | 9.49 |
| 01:08 ET | 952 | 9.5 |
| 01:10 ET | 1852 | 9.5 |
| 01:12 ET | 1000 | 9.52 |
| 01:14 ET | 100 | 9.52 |
| 01:15 ET | 356 | 9.5123 |
| 01:17 ET | 1116 | 9.52 |
| 01:19 ET | 300 | 9.515 |
| 01:21 ET | 500 | 9.52 |
| 01:24 ET | 100 | 9.53 |
| 01:28 ET | 100 | 9.51 |
| 01:30 ET | 2228 | 9.5 |
| 01:32 ET | 1000 | 9.51 |
| 01:33 ET | 200 | 9.505 |
| 01:35 ET | 3234 | 9.53 |
| 01:37 ET | 600 | 9.54 |
| 01:39 ET | 700 | 9.5391 |
| 01:42 ET | 900 | 9.5299 |
| 01:44 ET | 900 | 9.53 |
| 01:46 ET | 500 | 9.53 |
| 01:48 ET | 600 | 9.54 |
| 01:50 ET | 100 | 9.54 |
| 01:53 ET | 2471 | 9.55 |
| 01:55 ET | 1400 | 9.57 |
| 01:57 ET | 300 | 9.56 |
| 02:02 ET | 2214 | 9.57 |
| 02:04 ET | 150 | 9.57 |
| 02:06 ET | 2767 | 9.58 |
| 02:08 ET | 1667 | 9.57 |
| 02:09 ET | 2472 | 9.59 |
| 02:11 ET | 5331 | 9.61 |
| 02:13 ET | 243 | 9.61 |
| 02:15 ET | 600 | 9.61 |
| 02:18 ET | 500 | 9.61 |
| 02:20 ET | 400 | 9.62 |
| 02:22 ET | 1500 | 9.62 |
| 02:24 ET | 6105 | 9.63 |
| 02:26 ET | 400 | 9.63 |
| 02:27 ET | 1300 | 9.63 |
| 02:29 ET | 900 | 9.625 |
| 02:31 ET | 1428 | 9.6259 |
| 02:33 ET | 5491 | 9.61 |
| 02:38 ET | 1300 | 9.59 |
| 02:40 ET | 3196 | 9.595 |
| 02:42 ET | 3587 | 9.615 |
| 02:44 ET | 1259 | 9.62 |
| 02:45 ET | 529 | 9.63 |
| 02:47 ET | 4433 | 9.62 |
| 02:49 ET | 413 | 9.615 |
| 02:51 ET | 2100 | 9.63 |
| 02:54 ET | 2093 | 9.62 |
| 02:56 ET | 2000 | 9.59 |
| 02:58 ET | 1400 | 9.585 |
| 03:00 ET | 2400 | 9.58 |
| 03:02 ET | 1300 | 9.57 |
| 03:03 ET | 1549 | 9.555 |
| 03:05 ET | 1493 | 9.565 |
| 03:07 ET | 400 | 9.57 |
| 03:09 ET | 2895 | 9.58 |
| 03:12 ET | 500 | 9.58 |
| 03:14 ET | 1983 | 9.585 |
| 03:16 ET | 1207 | 9.585 |
| 03:18 ET | 3762 | 9.6 |
| 03:20 ET | 620 | 9.6 |
| 03:21 ET | 2105 | 9.62 |
| 03:23 ET | 2000 | 9.65 |
| 03:25 ET | 620 | 9.645 |
| 03:27 ET | 5563 | 9.63 |
| 03:30 ET | 2500 | 9.611 |
| 03:32 ET | 1500 | 9.591 |
| 03:34 ET | 1138 | 9.565 |
| 03:36 ET | 1000 | 9.565 |
| 03:38 ET | 5353 | 9.57 |
| 03:39 ET | 4854 | 9.521 |
| 03:41 ET | 300 | 9.53 |
| 03:43 ET | 5897 | 9.54 |
| 03:45 ET | 3075 | 9.57 |
| 03:48 ET | 2730 | 9.56 |
| 03:50 ET | 4531 | 9.54 |
| 03:52 ET | 5183 | 9.54 |
| 03:54 ET | 7872 | 9.52 |
| 03:56 ET | 5715 | 9.57 |
| 03:57 ET | 8151 | 9.555 |
| 03:59 ET | 13537 | 9.57 |
Jun 26, 2024
DJ Vir Biotechnology's Tobevibart, Elebsiran Combo Gets FDA Fast Track Status for Chronic Hepatitis Delta, from 8:36AM ET on Wednesday Jun 26, 2024 by Dow Jones
8:36AM ET on Wednesday Jun 26, 2024 by Dow JonesVir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection, from 8:05AM ET on Wednesday Jun 26, 2024 by Dow Jones
8:05AM ET on Wednesday Jun 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.3B | -2.4x | --- |
Prothena Corporation PLC | 1.2B | -6.9x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -3.7x | --- |
Immatics NV | 1.3B | -11.8x | --- |
Arcus Biosciences Inc | 1.4B | -5.0x | --- |
Gyre Therapeutics Inc | 1.1B | -7.4x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
|---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 16.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
